Phase Ib trial of brostallicin in combination with bevacizumab or irinotecan in patients with advanced solid tumours

Trial Profile

Phase Ib trial of brostallicin in combination with bevacizumab or irinotecan in patients with advanced solid tumours

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Dec 2008

At a glance

  • Drugs Brostallicin (Primary) ; Bevacizumab; Irinotecan
  • Indications Solid tumours
  • Focus Adverse reactions; Pharmacogenomic
  • Most Recent Events

    • 01 Nov 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top